Related Experiment Video
Updated: Jul 6, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin
Mahtab Moayeri1, Tanisha M Robinson, Stephen H Leppla
1Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Abstract:
We evaluated the in vivo efficacy of three beta-cyclodextrin derivatives that block the anthrax protective antigen pore. These compounds were at least 15-fold more potent than previously described beta-cyclodextrins in protecting against anthrax lethal toxin in a rat model. One of the drugs was shown to protect mice from bacterial infection.
Related Concept Videos
Inhalation Anthrax
Bacterial Toxins
